ASKA Pharmaceutical Company Overview
- Year Founded
-
1920
- Status
-
Public
- Employees
-
1,769
- Stock Symbol
-
4886
- Investments
-
6
- Share Price
-
$16.97
- (As of Monday Closing)
ASKA Pharmaceutical Company General Information
Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.
Contact Information
Website
www.aska-pharma.co.jpCorporate Office
- 5-1 Shibaura 2-chome
- Minato-Ku
- Tokyo, 108-8532
- Japan
Corporate Office
- 5-1 Shibaura 2-chome
- Minato-Ku
- Tokyo, 108-8532
- Japan
ASKA Pharmaceutical Company Stock Performance
As of 07-Jul-2025, ASKA Pharmaceutical Company’s stock price is $16.97. Its current market cap is $481M with 28.4M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.97 | $16.99 | $11.75 - $17.47 | $481M | 28.4M | 41.6K | $1.18 |
ASKA Pharmaceutical Company Financials Summary
As of 31-Mar-2025, ASKA Pharmaceutical Company has a trailing 12-month revenue of $421M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 |
|---|---|---|---|---|
| EV | 419,254 | 419,254 | 341,966 | 209,303 |
| Revenue | 420,623 | 420,623 | 434,930 | 446,596 |
| EBITDA | 55,638 | 55,638 | 86,927 | 63,037 |
| Net Income | 33,452 | 33,452 | 52,218 | 31,304 |
| Total Assets | 671,829 | 671,829 | 599,571 | 653,962 |
| Total Debt | 72,854 | 72,854 | 62,669 | 94,734 |
ASKA Pharmaceutical Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ASKA Pharmaceutical Company Patents
ASKA Pharmaceutical Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4553068-A1 | Pyrimidine derivatives | Pending | 06-Jul-2022 | ||
| EP-4410806-A1 | Degradation inducer | Pending | 30-Sep-2021 | ||
| US-20240425456-A1 | Degrader | Pending | 30-Sep-2021 | ||
| JP-2022134885-A | Pharmaceutical composition for treating or preventing hyperammonemia | Pending | 04-Mar-2021 | ||
| AU-2022217610-A1 | Pyrimidine derivative | Pending | 02-Feb-2021 | C07D401/04 |
ASKA Pharmaceutical Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ASKA Pharmaceutical Company Investments (6)
ASKA Pharmaceutical Company’s most recent deal was a Early Stage VC with ARCS for . The deal was made on 12-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ARCS | 12-May-2025 | Early Stage VC | Other Healthcare Technology Systems | ||
| Famione | 26-Sep-2024 | Later Stage VC | Information Services (B2C) | ||
| TesoRx Pharma | 01-Dec-2017 | Later Stage VC | Drug Delivery | ||
| TesoRx Pharma | 20-Oct-2014 | Early Stage VC | Drug Delivery | ||
| Ceolia Pharma | 01-Apr-2010 | Joint Venture | Pharmaceuticals |
ASKA Pharmaceutical Company ESG
Risk Overview
Risk Rating
Updated December, 21, 2024
29.77 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Pharmaceuticals
Subindustry
of 420
Rank
Percentile
ASKA Pharmaceutical Company FAQs
-
When was ASKA Pharmaceutical Company founded?
ASKA Pharmaceutical Company was founded in 1920.
-
Where is ASKA Pharmaceutical Company headquartered?
ASKA Pharmaceutical Company is headquartered in Tokyo, Japan.
-
What is the size of ASKA Pharmaceutical Company?
ASKA Pharmaceutical Company has 1,769 total employees.
-
What industry is ASKA Pharmaceutical Company in?
ASKA Pharmaceutical Company’s primary industry is Pharmaceuticals.
-
Is ASKA Pharmaceutical Company a private or public company?
ASKA Pharmaceutical Company is a Public company.
-
What is ASKA Pharmaceutical Company’s stock symbol?
The ticker symbol for ASKA Pharmaceutical Company is 4886.
-
What is the current stock price of ASKA Pharmaceutical Company?
As of 07-Jul-2025 the stock price of ASKA Pharmaceutical Company is $16.97.
-
What is the current market cap of ASKA Pharmaceutical Company?
The current market capitalization of ASKA Pharmaceutical Company is $481M.
-
What is ASKA Pharmaceutical Company’s current revenue?
The trailing twelve month revenue for ASKA Pharmaceutical Company is $421M.
-
What is ASKA Pharmaceutical Company’s annual earnings per share (EPS)?
ASKA Pharmaceutical Company’s EPS for 12 months was $1.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
